12.73 (-%)
As of Dec 10, 2024
Source:
Celcuity Inc is a clinical-stage biotechnology company focused on development of targeted therapies for treatment of multiple solid tumor indications. Our lead therapeutic candidate is gedatolisib, a pan-PI3K/mTOR inhibitor.
Country | United States |
Headquarters | minneapolis, minnesota |
Phone Number | 763-392-0767 |
Industry | services |
CEO | Brian F. Sullivan |
Website | www.celcuity.com |